吸入薄荷醇对慢阻肺患者骑行运动时呼吸困难的影响:一项随机试验
薄荷醇降低了系列呼吸困难强度评分,且运动末呼吸困难不愉快感、空气饥饿感和精神呼吸努力均更低,但运动耐力时间无差异,85%患者报告薄荷醇使吸气气流更轻松。
要点
- 薄荷醇吸入可降低慢阻肺患者运动中的呼吸困难强度及不愉快感。
- 薄荷醇未改变通气与神经肌肉参数,也未延长运动耐力时间。
- 85%患者主观感觉薄荷醇使吸气气流更轻松。
核心结论
- 薄荷醇吸入可能有助于部分慢阻肺患者运动性呼吸困难的管理。
主要发现
- 85%患者报告薄荷醇使吸气气流更轻松。
临床怎么用
- 对于部分慢阻肺患者,可考虑吸入薄荷醇以缓解运动性呼吸困难。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Menthol inhalation (MI) lowers dyspnea ratings during loaded breathing in COPD and cycle exercise in healthy adults. Proposed mechanisms include stimulation of cold receptors in the upper airways, modulating perception of breathing-related effort and airflow. RESEARCH QUESTION: Does MI also alleviate exertional dyspnea in COPD? STUDY DESIGN AND METHODS: Twenty patients with COPD (60% male; mean age ± SD, 68 ± 6 years; FEV1, 47% ± 17% predicted) completed 2 constant-load cycle exercise tests (73% ± 7% peak power output) to exhaustion with menthol or placebo (strawberry flavoring) added to the breathing circuit in counterbalanced order and on separate days. Ventilatory and neuromuscular parameters were measured continuously. Dyspnea intensity was serially assessed using the 0 to 10 category ratio Borg scale, and dyspnea unpleasantness and related sensory qualities were assessed using the Multidimensional Dyspnea Profile at end exercise. Participants were asked in which test their inspiratory airflow felt easier. RESULTS: Serial dyspnea intensity ratings were lower with menthol vs placebo (estimate [Δ/10% peak time]: -0.09; 95% CI, -0.15 to -0.02; P = .01), whereas ratings of dyspnea unpleasantness, air hunger, and mental breathing effort were lower at end exercise (all P < .05). Menthol-related improvements in dyspnea intensity at symptom limitation of the shorter test vs equivalent time on the other were correlated with higher endurance time (r = -0.73, P < .001). There were no differences in ventilatory and neuromuscular parameters (P > .05). Exercise endurance time was unaffected by menthol (Δ 0.3 ± 1.6 minutes with menthol vs placebo; P = .50). A total of 85% reported easier inspiratory airflow with menthol. INTERPRETATION: MI may be useful for management of exertional dyspnea in selected patients with COPD. Future work should investigate if MI can improve outcomes of exercise rehabilitation programs. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT05785026; URL: www. CLINICALTRIALS: gov.
引用
- Schaeffer MR, Vanden Bossche L, Beckers K, et al. Inhaled Menthol for Dyspnea Relief During Cycle Exercise in COPD: A Randomized Trial. Chest. 2025. PMID: 40088943. doi:10.1016/j.chest.2025.03.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。